FDA Recall Open, Classified

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Recall: Z-2067-2026 · Initiated April 22, 2026

Recall

Recall Number
Z-2067-2026
Event Number
98776
Firm
BioFire Diagnostics, LLC
FEI Number
3002773840
Product Code
QSN
Status
Open, Classified
Root Cause
Under Investigation by firm
Initiated
April 22, 2026
Posted
May 6, 2026
Address
515 S Colorow Dr, Salt Lake City, UT, 84108-1248

Description

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Reason

Contamination to in-vitro diagnostic test may result in false positives.

Action

On April 22, 2026, bioMerieux issued a Urgent Medical Device Recall notification to affected consignees via E-Mail. bioMerieux asked consignees to take the following actions: 1 Examine your inventory for the lots identified in this recall notification. 2 Discontinue use and discard any remaining product from this lot in your possession. 3 Please confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. 4 If the product has been transferred to another facility, please notify the facility and appropriate personnel. 5 If you have further distributed this product, please identify any recipients and notify them at once. 6 Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification.

Distribution

Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.

Quantity

106 kits (3,180 test)